Editorial comment on: Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.
Eden
Christopher G
CG
D007172:Erectile Dysfunction / Q000209:etiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D008297:Male; D009416:Nerve Regeneration / Q000502:physiology; D010410:Penile Erection / Q000502:physiology*; D010413:Penis / Q000294:innervation; D011336:Probability; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery; D013497:Sural Nerve / Q000637:transplantation*; D016378:Tissue Transplantation; D016896:Treatment Outcome